In experimental design, what is the role of the control group, and how does randomization influence bias?

In experimental design, what is the role of the control group, and how does randomization influence bias?

• A. It provides a baseline for comparison; randomization distributes confounding variables evenly, reducing bias.
• B. It accelerates data collection by testing more conditions and variables at once.
• C. It ensures that every variable is fully controlled with no uncontrolled factors.
• D. It guarantees a larger sample size so results are always significant.

Answer: (A)

The main idea is using a baseline for comparison and reducing bias through fair group assignment. The control group provides what happens without the treatment, so you can see how outcomes change when the treatment is applied. That baseline lets you attribute observed effects more confidently to the treatment itself rather than to other factors. Randomization strengthens this by giving each participant an equal chance to be in any group. That tends to spread both known and unknown confounding factors—like age, health, or lifestyle—across groups, so those factors don’t systematically skew the results. With confounders distributed evenly, differences in outcomes are more likely due to the treatment, which lowers bias and improves the study’s validity. The other ideas don’t fit as well. Accelerating data collection by testing more conditions describes a broader design approach, not the role of the control group. Expecting complete control of every variable isn’t realistic; randomization reduces but doesn’t eliminate all uncontrolled factors. Merely increasing sample size boosts statistical power, not the fundamental function of the control group or the bias-reducing effect of randomization.

The main idea is using a baseline for comparison and reducing bias through fair group assignment. The control group provides what happens without the treatment, so you can see how outcomes change when the treatment is applied. That baseline lets you attribute observed effects more confidently to the treatment itself rather than to other factors.

Randomization strengthens this by giving each participant an equal chance to be in any group. That tends to spread both known and unknown confounding factors—like age, health, or lifestyle—across groups, so those factors don’t systematically skew the results. With confounders distributed evenly, differences in outcomes are more likely due to the treatment, which lowers bias and improves the study’s validity.

The other ideas don’t fit as well. Accelerating data collection by testing more conditions describes a broader design approach, not the role of the control group. Expecting complete control of every variable isn’t realistic; randomization reduces but doesn’t eliminate all uncontrolled factors. Merely increasing sample size boosts statistical power, not the fundamental function of the control group or the bias-reducing effect of randomization.